[Upcoming Webinar] Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach

In an upcoming webinar, Sr. Director of Clinical Trial Management Jennifer Brown and Advanced Clinical Practitioners Amanda Sylvester, DNP, APRN, CPNP-BC and Prudence King, MSN, APRN, AGPCNP-BC will explore innovative strategies to enhance obesity clinical trials and share practical approaches for maximizing patient retention and protecting endpoint integrity. Register now to reserve your spot.

Expert Panelists:

The global obesity epidemic continues to rise, presenting a serious public health challenge. Studies show that more than 1 billion people worldwide are classified as obese, with rates doubling among adults, and quadrupling among children and adolescents since 1990. The associated risks - such as cardiovascular diseases, diabetes and certain cancers - underscore the urgent need for effective intervention strategies.

Addressing obesity through the clinical trials of anti-obesity drugs requires innovative, patient-centered approaches. In this webinar, the speakers will provide insights improving obesity clinical trial outcomes, with a focus on strategies to maximize patient retention. Additionally, this webinar will highlight the importance of endpoint protection to ensure the integrity and reliability of the trial's results.

Register for this webinar today to learn how maximizing patient retention and protecting endpoint integrity are making a significant impact on the success of obesity clinical trials.

Cutting-Edge Trial Design & Execution in Obesity

The Medpace medical, operations, and regulatory staff understand the complexities of obesity trials from the perspective of the Sponsor, the clinical investigator, the scientific leader, and the reviewer at the regulatory agencies. Our matured relationships with global thought leaders, investigative sites, the Medpace global 'flagship' metabolic site network, and patient advocacy groups, as well as knowledge of effective patient retention strategies, ensure efficient and quality patient enrollment which is key to the success of these programs.

In addition to therapeutically specialized, full-service CRO offerings, Medpace provides comprehensive and fully integrated global central lab services, a bioanalytical lab, an imaging core lab, an ECG core lab, and a Phase I unit. The built-in collaboration and efficiencies of working with a single vendor facilitates a streamlined strategy for executing trials of all sizes and scope.

Public link

Please use the above public link if you want to share this noodl on another website.